ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting

PURPOSE: The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients. METHODS: A total of 166 high risk stages II and III colon cancer patients were retrospectiv...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Coloproctol
Päätekijät: Kim, Chee Young, Seo, Sang Hyuk, An, Min Sung, Kim, Kwang Hee, Bae, Ki Beom, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Society of Coloproctology 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://ncbi.nlm.nih.gov/pubmed/26161376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/ac.2015.31.3.92
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia